NVO - Novo Nordisk

-

$undefined

N/A

(N/A)

Novo Nordisk NEW YORK STOCK EXCHANGE INC.:NVO Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries, and affiliates or offices in five countries.

Location: Bagsvaerd, 2880, Denmark | Website: https://www.novonordisk.com/ | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

340.8B

Cash

74.88B

Avg Qtr Burn

N/A

Short % of Float

0.26%

Insider Ownership

0.00%

Institutional Own.

10.14%

Qtr Updated

09/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Alhemo® (concizumab) Details
Hemophilia, Blood disorder

Approved

Quarterly sales

Once-weekly basal insulin icodec Details
Diabetes mellitus , Type 1 diabetes

BLA

Resubmission

CagriSema Details
Obesity, Type 2 diabetes

Phase 3

Data readout

Phase 3

Data readout

Phase 2/3

Update

FT-7051 (CBP/P300 inhibitor) Details
Castration-resistant prostate cancer

Failed

Discontinued